Results 21 to 30 of about 435,562 (349)

Risk of Progression of Nonalbuminuric CKD to End-Stage Kidney Disease in People With Diabetes: The CRIC (Chronic Renal Insufficiency Cohort) Study.

open access: yesAmerican Journal of Kidney Diseases, 2018
BACKGROUND Reduced glomerular filtration rate (GFR) in the absence of albuminuria is a common manifestation of chronic kidney disease (CKD) in diabetes.
D. Koye   +6 more
semanticscholar   +1 more source

Cardiac Biomarkers and Risk of Incident Heart Failure in Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study

open access: yesJournal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2019
Background Cardiac biomarkers may signal mechanistic pathways involved in heart failure (HF), a leading complication in chronic kidney disease. We tested the associations of NT‐proBNP (N‐terminal pro‐B‐type natriuretic peptide), high‐sensitivity troponin
N. Bansal   +16 more
semanticscholar   +1 more source

Dialysotherapy effect on the quality of life for renal patients

open access: yesJournal of Education, Health and Sport, 2023
The purpose of this essay is to examine how dialysis treatment affects patients' quality of life at the Department of Nephrology. The course of chronic renal disease and its management greatly influence the standard of living for dialysis patients ...
Aleksandra Kułakowska   +4 more
doaj   +1 more source

FGF23, PTH and Phosphorus Metabolism in the Chronic Renal Insufficiency Cohort

open access: yesKidney International, 2011
Fibroblast growth factor 23 (FGF23) regulates phosphorus metabolism and is a strong predictor of mortality in dialysis patients. FGF23 has been proposed as an early biomarker of disordered phosphorus metabolism in earlier stages of chronic kidney disease
T. Isakova   +18 more
semanticscholar   +1 more source

Glucose-induced down regulation of thiamine transporters in the kidney proximal tubular epithelium produces thiamine insufficiency in diabetes [PDF]

open access: yes, 2012
Increased renal clearance of thiamine (vitamin B1) occurs in experimental and clinical diabetes producing thiamine insufficiency mediated by impaired tubular re-uptake and linked to the development of diabetic nephropathy.
Larkin James R.   +22 more
core   +1 more source

Evaluation of oxidative stress biomarkers in patients with chronic renal failure: a case control study

open access: yesBMC Research Notes, 2010
Background Oxidative stress is related to several diseases, including chronic renal insufficiency. The disequilibrium in the oxidant-antioxidant balance is the result of several metabolic changes.
Martinez-Vea Alberto   +7 more
doaj   +1 more source

Musculoskeletal and Peripheral Nervous System Involvement in a Patient Undergoing Chronic Hemodialysis: A Case Report and Literature Review

open access: yesTürk Osteoporoz Dergisi, 2021
Musculoskeletal system manifestations in chronic renal insufficiency are caused by complex bone metabolism alterations, which is now described under the umbrella term of chronic kidney disease mineral- and bone-related disorder instead of renal ...
Zeynep Tuba Bahtiyarca   +1 more
doaj   +1 more source

Inflammation and Cardiovascular Disease Associated With Hemodialysis for End-Stage Renal Disease

open access: yesFrontiers in Pharmacology, 2022
Chronic kidney disease (CKD) and cardiac insufficiency often co-exist, particularly in uremic patients on hemodialysis (HD). The occurrence of abnormal renal function in patients with cardiac insufficiency is often indicative of a poor prognosis.
Yinghui Wang, Lu Gao
doaj   +1 more source

Risk Factors for Heart Failure in Patients With Chronic Kidney Disease: The CRIC (Chronic Renal Insufficiency Cohort) Study

open access: yesJournal of the American Heart Association : Cardiovascular and Cerebrovascular Disease, 2017
Heart failure is common in patients with chronic kidney disease. We studied risk factors for incident heart failure among 3557 participants in the CRIC (Chronic Renal Insufficiency Cohort) Study.
Jiang He   +19 more
semanticscholar   +1 more source

Lapatinib and chronic renal insufficiency

open access: yesAboutOpen, 2018
Lapatinib is an intracellular tyrosine-kinase inhibitor of both EGFR (ErbB1) and HER2 (ErbB2) receptors, which is indicated in the treatment of metastatic disease pretreated with anti-HER2 therapies.
Luca Moscetti
doaj   +1 more source

Home - About - Disclaimer - Privacy